Results 11 to 20 of about 182,387 (331)

Endogenous inhibitors of angiogenesis [PDF]

open access: greenJournal of Cell Science, 2001
In the course of embryonic development, during some normal physiological processes in the adult, such as the female reproductive cycle, and also in a variety of pathologies, including tumour growth, new blood vessels develop from the pre-existing vascular network through endothelial cell sprouting,
Christiana Ruhrberg
openalex   +6 more sources

Cardiotoxic effects of angiogenesis inhibitors. [PDF]

open access: yesClin Sci (Lond), 2021
Abstract The development of new therapies for cancer has led to dramatic improvements in survivorship. Angiogenesis inhibitors represent one such advancement, revolutionising treatment for a wide range of malignancies. However, these drugs are associated with cardiovascular toxicities which can impact optimal cancer treatment in the ...
Dobbin SJH   +4 more
europepmc   +6 more sources

Thalidomide is an inhibitor of angiogenesis. [PDF]

open access: yesProceedings of the National Academy of Sciences, 1994
Thalidomide is a potent teratogen causing dysmelia (stunted limb growth) in humans. We have demonstrated that orally administered thalidomide is an inhibitor of angiogenesis induced by basic fibroblast growth factor in a rabbit cornea micropocket assay.
Michael S. Loughnan   +3 more
openaire   +4 more sources

Angiogenesis Inhibitors in NSCLC. [PDF]

open access: yesInt J Mol Sci, 2017
Angiogenesis is a complex biological process that plays a relevant role in sustaining the microenvironment, growth, and metastatic potential of several tumors, including non-small cell lung cancer (NSCLC). Bevacizumab was the first angiogenesis inhibitor approved for the treatment of patients with advanced NSCLC in combination with chemotherapy ...
Manzo A   +10 more
europepmc   +5 more sources

Normal Wound Healing and Tumor Angiogenesis as a Game of Competitive Inhibition. [PDF]

open access: yesPLoS ONE, 2016
Both normal wound healing and tumor angiogenesis are mitigated by the sequential, carefully orchestrated release of growth stimulators and inhibitors.
Irina Kareva   +4 more
doaj   +1 more source

Computational modelling of angiogenesis: The importance of cell rearrangements during vascular growth [PDF]

open access: yesWIREs Mechanisms of Disease, e1634 (2023), 2023
Angiogenesis is the process wherein endothelial cells (ECs) form sprouts that elongate from the pre-existing vasculature to create new vascular networks. In addition to its essential role in normal development, angiogenesis plays a vital role in pathologies such as cancer, diabetes and atherosclerosis.
arxiv   +1 more source

The Role of a Single Angiogenesis Inhibitor in the Treatment of Recurrent Glioblastoma Multiforme: A Meta-Analysis and Systematic Review. [PDF]

open access: yesPLoS ONE, 2016
Currently, the standard treatment for newly diagnosed glioblastoma multiforme (GBM) is maximal safe surgical resection followed by radiation therapy with concurrent and adjuvant temozolomide.
Yawei Wang   +4 more
doaj   +1 more source

Multi-Omics Analysis of Anlotinib in Pancreatic Cancer and Development of an Anlotinib-Related Prognostic Signature

open access: yesFrontiers in Cell and Developmental Biology, 2021
Aberrant regulation of angiogenesis involves in the growth and metastasis of tumors, but angiogenesis inhibitors fail to improve overall survival of pancreatic cancer patients in previous phase III clinical trials.
Xi Zhang   +7 more
doaj   +1 more source

The Vasohibin Family

open access: yesPharmaceuticals, 2010
Angiogenesis is regulated by the local balance between angiogenesis stimulators and inhibitors. A number of endogenous angiogenesis inhibitors have been found in the body. The origin of these inhibitors is mostly extrinsic to the vasculature.
Yasufumi Sato
doaj   +1 more source

Efficacy and safety of angiogenesis inhibitors in advanced gastric cancer: a systematic review and meta-analysis

open access: yesJournal of Hematology & Oncology, 2016
Monoclonal antibodies and small molecule tyrosine kinase inhibitors (TKIs) directed against the vascular endothelial growth factor (VEGF) or its receptors have been investigated in several studies for the treatment of advanced gastric cancer (GC). In the
Jing Yu   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy